FCAS and all CAPS conditions result from mutations in the NLRP3 (NOD-like receptor family pyrin domain containing 3) gene, which encodes NLRP3/cryopyrin, a component of the inflammasome complex that regulates IL-1β production.7 This evidence concerns the gene NLRP3 and cryopyrin-associated periodic syndrome.